These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25458333)

  • 1. Real-time continuous glucose monitoring versus internet-based blood glucose monitoring in adults with type 2 diabetes: a study of treatment satisfaction.
    Tang TS; Digby EM; Wright AM; Chan JH; Mazanderani AB; Ross SA; Tildesley HG; Lee AM; White AS; Tildesley HD
    Diabetes Res Clin Pract; 2014 Dec; 106(3):481-6. PubMed ID: 25458333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of internet monitoring with continuous glucose monitoring in insulin-requiring type 2 diabetes mellitus.
    Tildesley HD; Wright AM; Chan JH; Mazanderani AB; Ross SA; Tildesley HG; Lee AM; Tang TS; White AS
    Can J Diabetes; 2013 Oct; 37(5):305-8. PubMed ID: 24500556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study.
    Pazos-Couselo M; García-López JM; González-Rodríguez M; Gude F; Mayán-Santos JM; Rodríguez-Segade S; Rodríguez-García J; Casanueva F
    Can J Diabetes; 2015 Oct; 39(5):428-33. PubMed ID: 26254702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: A Comparison of Internet Monitoring with Continuous Glucose Monitoring in Insulin-Requiring Type 2 Diabetes Mellitus.
    Tildesley HD; Wright AM; Chan JH; Mazanderani AB; Ross SA; Tildesley HG; Lee AM; Tang TS; White AS
    Can J Diabetes; 2016 May; 40 Suppl 1():24-7. PubMed ID: 27283091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy.
    Jendle J; Testa MA; Martin S; Jiang H; Milicevic Z
    Diabetes Obes Metab; 2016 Oct; 18(10):999-1005. PubMed ID: 27279266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen.
    Gómez AM; Umpierrez GE; Muñoz OM; Herrera F; Rubio C; Aschner P; Buendia R
    J Diabetes Sci Technol; 2015 Aug; 10(2):325-9. PubMed ID: 26330394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there an optimal strategy for real-time continuous glucose monitoring in pediatrics? A 12-month French multi-center, prospective, controlled randomized trial (Start-In!).
    Guilmin-Crépon S; Carel JC; Schroedt J; Sulmont V; Salmon AS; Le Tallec C; Coutant R; Dalla-Vale F; Stuckens C; Bony-Trifunovic H; Crosnier H; Kurtz F; Kaguelidou F; Le Jeannic A; Durand-Zaleski I; Couque N; Alberti C; Tubiana-Rufi N
    Pediatr Diabetes; 2019 May; 20(3):304-313. PubMed ID: 30663187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes.
    Vigersky RA; Fonda SJ; Chellappa M; Walker MS; Ehrhardt NM
    Diabetes Care; 2012 Jan; 35(1):32-8. PubMed ID: 22100963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time continuous glucose monitoring systems in the classroom/school environment.
    Benassi K; Drobny J; Aye T
    Diabetes Technol Ther; 2013 May; 15(5):409-12. PubMed ID: 23530577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T).
    Levy JC; Davies MJ; Holman RR;
    Diabetes Res Clin Pract; 2017 Sep; 131():161-168. PubMed ID: 28750219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study).
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Pehrsson NG; Moström P
    J Diabetes Sci Technol; 2016 May; 10(3):754-61. PubMed ID: 27081191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
    Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
    Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections.
    Volčanšek Š; Lunder M; Janež A
    Diabetes Technol Ther; 2019 Oct; 21(10):566-574. PubMed ID: 31335199
    [No Abstract]   [Full Text] [Related]  

  • 17. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and acceptability of real-time continuous glucose monitoring and its impact on diabetes management behaviours in individuals with Type 2 Diabetes - A pilot study.
    Taylor PJ; Thompson CH; Luscombe-Marsh ND; Wycherley TP; Wittert G; Brinkworth GD; Zajac I
    Diabetes Res Clin Pract; 2019 Sep; 155():107814. PubMed ID: 31421138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes.
    Fonda SJ; Graham C; Munakata J; Powers JM; Price D; Vigersky RA
    J Diabetes Sci Technol; 2016 Jul; 10(4):898-904. PubMed ID: 26843480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.